Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Blood Neoplasia
|
July 12, 2026
CD8<sup>+</sup>CD38<sup>+</sup> T cells identify functional high-risk multiple myeloma after autologous transplant: BMT CTN 0702 correlates
Nezar Mehanna, Andriy Derkach, Billel Gasmi, et al.
Blood
|
September 25, 2025
Genomic landscape of IgM-MGUS and patients with stable or progressive asymptomatic Waldenström macroglobulinemia
Tina Bagratuni, Ourania Theologi, Christos Vlachos, et al.
Blood Cancer Journal
|
July 25, 2023
Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
Carlyn Rose Tan, Andriy Derkach, David Nemirovsky, et al.
Blood Advances
|
September 29, 2023
Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups
Urvi A Shah, Erin Moshier, Andriy Derkach, et al.
Research Square
|
February 26, 2024
Comparison of Infectious Complications with BCMA-directed Therapies in Multiple Myeloma
Alexander Lesokhin, Karthik Nath, Tala Shekarkhand, et al.
Blood Neoplasia
|
June 27, 2025
Belantamab mafodotin in patients with relapsed/refractory multiple myeloma: a real-world experience
Malin Hultcrantz, Andriy Derkach, Hani Hassoun, et al.
Transplantation and Cellular Therapy
|
May 23, 2022
Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma
Sarah A Holstein, Fotis Asimakopoulos, Abdel Kareem Azab, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2024
Mutagenic impact and evolutionary influence of radiotherapy in hematologic malignancies
Benjamin Diamond, Dhanvantri Chahar, Michael D Jain, et al.
Blood Cancer Journal
|
May 27, 2024
Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma
Bruno Almeida Costa, Jessica Flynn, Noriko Nishimura, et al.
Blood Cancer Journal
|
May 31, 2024
Comparison of infectious complications with BCMA-directed therapies in multiple myeloma
Karthik Nath, Tala Shekarkhand, David Nemirovsky, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Blood Neoplasia
|
July 12, 2026
CD8<sup>+</sup>CD38<sup>+</sup> T cells identify functional high-risk multiple myeloma after autologous transplant: BMT CTN 0702 correlates
Nezar Mehanna, Andriy Derkach, Billel Gasmi, et al.
Blood
|
September 25, 2025
Genomic landscape of IgM-MGUS and patients with stable or progressive asymptomatic Waldenström macroglobulinemia
Tina Bagratuni, Ourania Theologi, Christos Vlachos, et al.
Blood Cancer Journal
|
July 25, 2023
Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
Carlyn Rose Tan, Andriy Derkach, David Nemirovsky, et al.
Blood Advances
|
September 29, 2023
Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups
Urvi A Shah, Erin Moshier, Andriy Derkach, et al.
Research Square
|
February 26, 2024
Comparison of Infectious Complications with BCMA-directed Therapies in Multiple Myeloma
Alexander Lesokhin, Karthik Nath, Tala Shekarkhand, et al.
Blood Neoplasia
|
June 27, 2025
Belantamab mafodotin in patients with relapsed/refractory multiple myeloma: a real-world experience
Malin Hultcrantz, Andriy Derkach, Hani Hassoun, et al.
Transplantation and Cellular Therapy
|
May 23, 2022
Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma
Sarah A Holstein, Fotis Asimakopoulos, Abdel Kareem Azab, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2024
Mutagenic impact and evolutionary influence of radiotherapy in hematologic malignancies
Benjamin Diamond, Dhanvantri Chahar, Michael D Jain, et al.
Blood Cancer Journal
|
May 27, 2024
Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma
Bruno Almeida Costa, Jessica Flynn, Noriko Nishimura, et al.
Blood Cancer Journal
|
May 31, 2024
Comparison of infectious complications with BCMA-directed therapies in multiple myeloma
Karthik Nath, Tala Shekarkhand, David Nemirovsky, et al.
Page
of 4